JULIA BRANCO: Open Payments
NPI 1245669316 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 55 payments from 19 companies in 2025. Trend: 2023 $736 · 2024 $1,033 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $157 |
| ABBVIE INC. | 10 | $149 |
| Novo Nordisk Inc | 9 | $137 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $57 |
| Lilly USA, LLC | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $34 |
| Abbott Laboratories | 2 | $30 |
Products named: PREVNAR 20, UBRELVY, JARDIANCE, VRAYLAR, Auvelity, Ozempic, Wegovy, SPRAVATO.
Industry payments across MO — which companies pay providers there.
